ANALOG DEVICES INC
For the period ended Mar 12, 2025. Filed Jan 27, 2025.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
Mar 12, 2025 · Filed Jan 27, 2025
Use the contents to explore the available documents and sections.
Contents
Proxy Summary
ADI at a Glance
Analog Devices, Inc. is a global semiconductor leader that bridges the physical and digital worlds and brings intelligence to the Edge where our solutions help customers transform raw data into actionable insights to make connected devices smarter and more responsive. And, by harnessing the power of artificial intelligence (AI) and machine learning at the Edge, we strive to significantly reduce complexity while increasing impact and innovation for our 125,000 global customers.
Background
| Founded: | 1965 |
|---|---|
| Headquarters: | Wilmington, MA |
| Employees: | ~24,000 |
| Office Locations: | 31 CountriesWorldwide sales, field applications, product development, design, service, and technical support |
| Products: | 75,000+ SKUs |
| Customers: | 125,000+ |
| Publicly Listed – Nasdaq: | ADI |
| Design Centers: | 70+ |
| Global Manufacturing: | United States (Massachusetts, Oregon, Washington) | Ireland | Philippines |Malaysia | Thailand |
Fiscal Year 2024 Revenue:$9.4B
Fiscal Year 2024 Performance Highlights
| $9.4B | 57.1% | 21.6% | $3.28 | $3.9B |
|---|---|---|---|---|
| Revenue | Gross Margin | Operating Margin | Diluted Earnings per Share | Operating Cash Flow |
| ~87% | 67.9% | 40.9% | $6.38 | $3.1B |
| Business-to-Business Revenue | Adjusted Gross Margin* | Adjusted Operating Margin* | Adjusted Diluted Earnings per Share* | Free Cash Flow* |
| >$21B | 10% | >450% |
|---|---|---|
| Cash Returned to Shareholders Over the Last 10 Years | 10-Year Dividend CAGR | 10-Year Total Shareholder Return |
- See Appendix B for additional information regarding non-GAAP financial measures and reconciliations of non-GAAP financial measures to their most directly comparable GAAP financial measures.
| 2025 Proxy Statement | 1 |
|---|
Executive Compensation
Our executive compensation programs are designed to attract, retain, and motivate top executive talent and align the interests of our executive officers and our shareholders.
Overview of CEO and Named Executive Officer Pay
Executive pay at ADI is strongly aligned with long-term company performance, with a significant portion of compensation delivered in long-term equity-based awards. The target compensation mix shown below is based on target compensation consisting of the annual rate of base salary for the fiscal year ended November 2, 2024 (fiscal year 2024) and short-term and long-term incentive targets approved by the Compensation and Talent Committee in fiscal year 2024.
Fiscal Year 2024 Target Compensation for CEO
Fiscal Year 2024 Target Compensation for Other Named Executive Officers (NEOs)(1)
(1)Consists of Richard C. Puccio, Jr., Vivek Jain, Gregory Bryant, and Anelise Sacks, but excludes James Mollica who served as Interim Chief Financial Officer for a portion of fiscal year 2024. Excludes Mr. Puccio’s new hire equity award.
Stock Performance Graph
Fiscal year 2024 compensation actions for our executive officers, including our NEOs, are supported by solid corporate performance and strong shareholder returns. The following graph compares cumulative total shareholder return on our common stock since November 2, 2019 with the cumulative total return of the Standard & Poor’s (S&P) 500 Index and the Nasdaq Composite Index. The graph assumes the investment of $100 on November 2, 2019 in our common stock, the S&P 500 Index, and the Nasdaq Composite Index and assumes all dividends are reinvested. Measurement points are the last trading day for each respective fiscal year.
| 2 | Proxy Summary |
Pay For Performance
A significant portion of the total target compensation for our executive officers, including our NEOs, is in the form of variable, performance-based incentive compensation, with only a small portion of the total target compensation provided in the form of “fixed” compensation. We believe this focuses our executives on achieving company objectives, supports a high-performing culture that attracts and retains highly-qualified executive talent, and aligns executives’ incentives with the creation of shareholder value. In addition, we believe our focus on variable, performance-based incentive compensation provides our executive officers an opportunity to benefit if we deliver stronger results and conversely, if we deliver weaker results, our executive officers will earn less compensation.
Compensation Feedback and Responsiveness
Prior to and following our 2024 Annual Meeting, as part of our annual outreach program, we met with shareholders representing over 36% of our total shares outstanding, as well as proxy advisory firms, to discuss executive compensation, corporate governance, and other ESG topics. Our Lead Independent Director or the Chair of our Compensation and Talent Committee participated in meetings with shareholders representing over 25% of our total shares outstanding and in meetings with proxy advisory firms. In response to the advisory say-on-pay vote that we received at the 2024 Annual Meeting of Shareholders (2024 Annual Meeting) and feedback that we received from shareholders, during fiscal year 2024 we made the changes described in the table below to our executive short-term variable cash incentive and long-term incentive programs. We believe these changes better align executive and shareholder interests, incentivize our executives to achieve short-term objectives that support our long-term strategy as well as focus on long-term financial growth, continue to focus on challenging performance metrics, and provide market competitive compensation to attract and retain top executive talent. A detailed discussion of shareholder feedback and our responsiveness related to executive compensation is in the Shareholder Engagement and Compensation Discussion and Analysis sections of this Proxy Statement.
| Executive Short-Term Variable Cash Incentive | Commencing in fiscal year 2025, we implemented the following changes:uDecreased the maximum payout factor from 3.0x to 2.5x, while keeping targets consistent year-over-year in accordance with our long-term strategy and financial modeluMoved to an annual assessment and payout |
|---|---|
| Long-Term Incentive Program | uCommencing with fiscal year 2024 grants, we moved to a cumulative three-year target for our Financial Metric PRSUs, strengthening our commitment to focus on long-term performance |
| 2025 Proxy Statement | 3 |
|---|
Our Board of Directors and Corporate Governance
Director Nominees
ADI’s Board of Directors is composed of a diverse, experienced group of global thought, business, and academic leaders. On January 9, 2025, James Champy informed our Board of Directors that he decided not to stand for re-election at the Annual Meeting. Consequently, Mr. Champy will retire as a director and the Board of Directors has reduced the size of the Board of Directors to eleven members, both as of the date of the Annual Meeting on March 12, 2025. Our Nominating and Corporate Governance Committee has recommended, and our Board of Directors has determined, to nominate all other current members of our Board of Directors for re-election at the Annual Meeting.
| Name | Independent | Age | DirectorSince | AuditCommittee | Compensation& TalentCommittee | Nominating &CorporateGovernanceCommittee | CorporateDevelopmentCommittee |
|---|---|---|---|---|---|---|---|
| VINCENT ROCHEChief Executive Officer and Chair of the Board of Directors Analog Devices, Inc. | 64 | 2013 | |||||
| STEPHEN M. JENNINGSLead Independent Director Former Principal of Deloitte LLP | ü | 63 | 2023 | l | |||
| ANDRÉ ANDONIAN Chief Executive Officer of Andonian Advisory Pte. Ltd., Chair of Asia Pacific and Strategic Advisor at Flagship Pioneering, and Senior Advisor – Senior Partner Emeritus at McKinsey & Company | ü | 62 | 2022 | l | l | ||
| EDWARD H. FRANK, Ph.D. Executive Chair of Gradient Technologies | ü | 68 | 2014 | l | l | ||
| LAURIE H. GLIMCHER, M.D. Professor of Medicine at Harvard Medical School and President Emerita of Dana-Farber Cancer Institute | ü | 73 | 2020 | l | |||
| KAREN M. GOLZ Former Global Vice Chair of Ernst & Young LLP | ü | 70 | 2018 | l | |||
| PETER B. HENRY, Ph.D.Class of 1984 Senior Fellow at Stanford University’s Hoover Institution and Senior Fellow at Stanford’s Freeman Spogli Institute for International Studies | ü | 55 | 2023 | l | l | ||
| MERCEDES JOHNSON Former Chief Financial Officer of Avago Technologies (now Broadcom) | ü | 70 | 2021 | l | |||
| RAY STATA Co-Founder and Former Chair of the Board of Directors of Analog Devices, Inc. | 90 | 1965 | |||||
| ANDREA F. WAINERExecutive Vice President, Rapid and Molecular Diagnostics, Abbott Laboratories | ü | 56 | 2025 | l | |||
| SUSIE WEE, Ph.D. Co-Founder and Chief Executive Officer of DevAI | ü | 55 | 2019 | l | |||
l - Chair l - Member
| 4 | Proxy Summary |
Board Profile
ADI’s directors contribute significant experience in the areas most relevant to overseeing our business and strategy. The below matrix provides a high-level summary of the experience and qualifications of our director nominees:
| Executive Leadership | 6/11 | International | 8/11 | Cybersecurity, Information Systems | 3/11 |
| Industry | 9/11 | Large Scale Operations, Manufacturing | 8/11 | Mergers and Acquisitions | 5/11 |
| Innovation and Emerging Technologies | 10/11 | Government Affairs, Public Policy | 3/11 | ESG (Including Sustainability, Human Capital, Human Rights, and Diversity) | 5/11 |
| Corporate Governance, Public Company Board | 8/11 | Strategy | 11/11 | ||
| Financial, Accounting, Auditing | 3/11 | Risk Management, Regulatory, Compliance | 2/11 | ||
| DIRECTOR NOMINEE AGE | INDEPENDENT DIRECTOR NOMINEE TENURE | DIRECTOR NOMINEE DIVERSITY |
|---|---|---|
| Average Age: 66 yearsMedian Age: 64 years | Average Independent Director Nominee Tenure: 3.6 years |
What’s NewWe periodically review our corporate governance policies and practices and compare them to those suggested by various authorities in corporate governance and the practices of other public companies. We believe that good corporate governance is important to ensure that ADI is managed for the long-term benefit of our shareholders. Updated items include: uContinued to expand the capabilities of the Board of Directors by adding Andrea F. Wainer, who brings deep expertise leading innovative businesses in the diagnostics and pharmaceutical industries to our Board of DirectorsuOur Board of Directors adopted resolutions approving and declaring the advisability of adopting amendments to our Articles of Organization to lower the voting requirement for the approval of certain matters from a supermajority to a simple majority voting standarduOur Board of Directors amended our Bylaws to allow shareholders holding 25% of our outstanding shares for at least one year to call a special meeting, reducing the previous 80% threshold, which the Board of Directors believes strikes an appropriate balance between enhancing our shareholders’ ability to act on matters important to them and protecting against the risk that a small number of shareholders whose interests may not be shared by a broad base of shareholders could trigger a special meeting, resulting in financial expenses and disruption to our businessuCommitted to including in each search for new directors qualified candidates who reflect diversity of experience, skills, and industry familiarity, as well as gender, racial, ethnic, sexual orientation, and geographic diversityuSpecifically designated oversight of climate matters to the Nominating and Corporate Governance Committee
Oversight by our Board
The Board of Directors reviews our overall performance, and its primary responsibility is to oversee the management of ADI and, in doing so, serve the best interests of ADI and its shareholders. The Board of Directors and each of its committees assesses risks associated with their respective areas of oversight. For example, in addition to financial reporting and related matters, the Audit Committee oversees our cybersecurity and information security programs, practices, and risk mitigation efforts. The Nominating and Corporate Governance Committee oversees our environmental, social, and governance (ESG) programs, practices, and reporting, including issues of significance relating to climate, sustainability, and social and governance activities. Our Compensation and Talent Committee is responsible for oversight of our enterprise-level strategies and programs relating to human capital management and diversity. For more information, see Corporate Governance—Oversight by our Board.
| 2025 Proxy Statement | 5 |
|---|
Shareholder Engagement Highlights
We conduct extensive investor outreach throughout the year involving our independent directors, senior management, investor relations, legal, and human resources departments. This helps management and our Board of Directors understand and focus on the issues that matter most to our shareholders, so ADI can address them effectively.
Since our inception as a public company, we have maintained an active engagement program with our shareholders, meeting with them extensively throughout the year as part of our investor outreach efforts.
How we Engage
| Summer | Fall | Winter | Spring | ||
| uEvaluate proxy season outcomes and trends, corporate governance best practices, and regulatory developmentsuPublish annual ESG report to inform stakeholders, including investors, about recent developments relating to ESG matters | uConduct outreach with top investors to understand their priorities and solicit feedback on governance topics, including ESG and compensationuShare investor feedback with our Board of Directors | uPublish Annual Report and Proxy StatementuConduct outreach with top investors to discuss items to be considered at the annual meeting, given matters to be considered, if neededuAnnual Meeting | |||
Prior to and following our 2024 Annual Meeting, as part of our annual outreach program, we reached out to shareholders collectively representing over 57% of our total shares outstanding and proxy advisory firms with an invitation to have discussions with their corporate governance teams. Shareholders representing over 36% of our total shares outstanding, as well as proxy advisory firms, accepted our engagement invitation. These meetings included members of our legal, ESG, compensation, human relations, and investor relations organizations. In addition, our Lead Independent Director or the Chair of our Compensation and Talent Committee participated in meetings with shareholders representing over 25% of our total shares outstanding and in meetings with proxy advisory firms.
| Contacted | Engaged | Director Participated |
|---|
We reviewed the key takeaways from these shareholder meetings with our Board of Directors, with the goal of continuing to evolve our corporate governance practices to best meet the needs of ADI and our shareholders. While some of the feedback received has led to enhancements to our practices and disclosure, we also received positive feedback regarding certain practices that reconfirmed that our programs continue to be effective from our shareholders’ perspective. For more information about the feedback we received from shareholders during fiscal year 2024 and actions we took in response, please see the Shareholder Engagement section of this Proxy Statement.
| 6 | Proxy Summary |
Voting Matters and Vote Recommendations
| Proposal | Items of Business | Board Recommendation | Page Reference |
|---|---|---|---|
| 1 | Election of 11 DirectorsuOur Board of Directors and Nominating and Corporate Governance Committee are committed to ensuring that our Board of Directors is composed of a highly capable group of directors who collectively span a broad range of leadership skills and provide a significant breadth of experience, knowledge, and abilities, relevant to ADI’s strategic vision, long-term objectives, and business activities to effectively represent the interests of shareholders, drive shareholder value, exercise sound judgment, and reflect our corporate values of integrity, honesty, and adherence to high ethical standards | FOR each director nominee | 8 |
| 2 | Advisory Approval of the Compensation of our Named Executive OfficersuOur executive compensation programs are designed to align pay outcomes with company performance, taking into account shareholder feedback and interests. The compensation paid to our named executive officers in 2024 was designed to drive continued successful operational and financial performance and to attract, motivate, reward, and retain top executive talent | FOR | 42 |
| 3 | Ratification of the Selection of Ernst & Young LLP as Independent Registered Public Accounting Firm for our Fiscal Year EndingNovember 1, 2025uErnst & Young LLP is an independent auditing firm with the required knowledge and experience to effectively audit our financial statements. Audit and non-audit services are pre-approved by the Audit Committee | FOR | 79 |
| 4 | Approval of Amendments to our Articles of OrganizationuOur Board of Directors has determined, subject to shareholder approval, to amend our Articles of Organization to provide that each matter for which Massachusetts corporate law provides a default supermajority voting standard will be decided by a simple majority standard | FOR | 87 |
| 2025 Proxy Statement | 7 |
|---|
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.